Clinical Trial Update: Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics [Phase 3]

View source ↗

Summary

Phase III trial update for the fentanyl transdermal patch in chronic intractable pain assessing effectiveness, safety, and pharmacokinetics has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Fentanyl Transdermal Patch (Matrix) (fentanyl)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Intractable | Phase 3 | Status: COMPLETED